Xin Lang Cai Jing·2026-01-15 03:53Group 1 - The core point of the news is that Sino Medical experienced a 5% drop in stock price, reaching 22.99 CNY per share, with a trading volume of 437 million CNY and a turnover rate of 4.45%, resulting in a total market capitalization of 9.565 billion CNY [1] - Sino Medical, established on September 21, 2007, and listed on October 30, 2019, specializes in the research, production, and sales of high-end interventional medical devices, focusing on cardiovascular, cerebrovascular, and structural heart disease treatment areas [1] - The revenue composition of Sino Medical is as follows: stents account for 59.76%, balloons for 32.68%, and other products for 7.56% [1] Group 2 - From the perspective of fund holdings, one fund under Guotai Haitong Asset Management has a significant position in Sino Medical, with the Guotai Haitong Quantitative Stock Selection Mixed Fund A (016466) holding 444,300 shares, representing 0.89% of the fund's net value, making it the top heavy stock [2] - The Guotai Haitong Quantitative Stock Selection Mixed Fund A was established on August 18, 2022, with a current scale of 599 million CNY, and has achieved a year-to-date return of 8.38%, ranking 1383 out of 8840 in its category [2] - The fund manager, Hu Chonghai, has a tenure of 4 years and 33 days, with the fund's total asset scale at 13.684 billion CNY, achieving the best return of 90.54% and the worst return of 0.74% during his tenure [2]